Hansa Biopharma to Attend Virtual Kidney Health Forum
Hansa Biopharma AB announced that CEO Renée Aguiar-Lucander will participate in the Virtual U.S. Bancorp / BTIG Kidney Health Forum. The company will discuss kidney health topics.
Lund, Sweden, October 13, 2026 – Hansa Biopharma AB announced today that its CEO, Renée Aguiar-Lucander, and COO and President US, Maria Törnsén, will participate in a fireside chat at the Virtual U.S. Bancorp / BTIG Kidney Health Forum on Wednesday, October 14, 2026.
The forum focuses on discussions within the kidney health sector. Hansa Biopharma's CFO, Adam Cutler, will also attend the event.
This participation provides an opportunity for Hansa Biopharma to share its perspectives on advancements and challenges in kidney disease treatment. The company is focused on developing new therapies for rare diseases.
Hansa Biopharma is listed on Nasdaq Stockholm under the ticker HNSA. The company aims to improve the lives of patients with rare and life-threatening conditions.